What is Factset Research Systems's earnings per share (EPS)?

Factset Research Systems (FDS) reported diluted earnings per share of $15.55 for fiscal year 2025. This represents a 11.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Factset Research Systems (FDS) Financials

FDS

Trailing 12 months to May 31, 2026

Revenue $2.4B +6.6% YoY

Net Income $566.0M +6.2% YoY

EPS (Diluted) $15.17 +9.5% YoY

Free Cash Flow $708.3M +22.9% YoY

Market Cap $10.3B as of Oct 14, 2026

Price / Sales 4.2x on $2.4B revenue, trailing 12 months to May 31, 2026

Price / Earnings 18.2x on $566.0M net income, trailing 12 months to May 31, 2026

Price / Book 5.1x on $2.0B equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 14, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended May 31, 2026 Reported Jul 1, 2026 Currency USD FYE August

Newest figures come from the 10-Q for Q3 FY2026, filed Jul 1, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the FDS SEC filings page.

Factset Research Systems (FDS) reported $2.4B in revenue over the twelve months to May 31, 2026, up 6.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI FDS FY2025 2026-10-03

FactSet's recurring cash generation is paired with improving operating margins, while debt has fallen but the short-term liquidity cushion has narrowed.

The key earnings-quality signal is that FY2025 operating cash flow reached $726M versus free cash flow of $617M, while the corresponding gap in FY2021 was smaller at $61M. That widening spread points to heavier reinvestment—especially capital spending—rather than a breakdown between reported profit and cash generation.

Operating efficiency improved: operating margin rose from 29.8% in FY2021 to 32.2% in FY2025, indicating that operating income grew faster than the cost base. Gross margin also moved from 50.6% to 52.7%, so the improvement was not limited to overhead management.

The balance-sheet posture became less debt-heavy: debt-to-equity declined from 1.5x in FY2022 to 0.6x in FY2025. However, the current ratio fell from 3.0x in FY2021 to 1.4x in FY2025, meaning debt reduction coincided with a smaller cushion of current assets over near-term obligations.

Financial Health Signals

Financial Health Score 68/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Factset Research Systems's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Factset Research Systems has an operating margin of 32.2%, meaning the company retains $32 of operating profit per $100 of revenue. This strong profitability earns a score of 95/100, reflecting efficient cost management and pricing power. This is up from 31.8% the prior year.

Growth

Factset Research Systems's revenue grew 5.4% year-over-year to $2.3B, a solid pace of expansion. This earns a growth score of 52/100.

Leverage

Factset Research Systems has a moderate D/E ratio of 0.63. This balance of debt and equity financing earns a leverage score of 44/100.

Liquidity

Factset Research Systems's current ratio of 1.40 indicates adequate short-term liquidity, earning a score of 38/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Factset Research Systems converts 26.6% of revenue into free cash flow ($617.5M). This strong cash generation earns a score of 93/100.

Returns

Factset Research Systems earns a strong 27.3% return on equity (ROE), meaning it generates $27 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 88/100. This is down from 28.1% the prior year.

Altman Z-Score Safe

4.85

Factset Research Systems scores 4.85, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($10.3B) relative to total liabilities ($2.1B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

6/9

Factset Research Systems passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

1.22x

For every $1 of reported earnings, Factset Research Systems generates $1.22 in operating cash flow ($726.3M OCF vs $597.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

12.96x

Factset Research Systems earns $12.96 in operating income for every $1 of interest expense ($748.3M vs $57.7M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$622.9M

YoY+6.4%

QoQ+1.9%

5Y CAGR+9.3%

10Y CAGR+8.0%

Factset Research Systems generated $622.9M in revenue in Q3 2026. This represents an increase of 6.4% from the same quarter a year earlier. Against the prior quarter it is up 1.9%.

EBITDA

$212.2M

YoY-9.7%

QoQ-7.2%

Factset Research Systems's EBITDA was $212.2M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 9.7% from the same quarter a year earlier. Against the prior quarter it is down 7.2%.

Net Income

$126.7M

YoY-14.7%

QoQ-4.8%

5Y CAGR+4.7%

10Y CAGR+6.6%

Factset Research Systems reported $126.7M in net income in Q3 2026. This represents a decrease of 14.7% from the same quarter a year earlier. Against the prior quarter it is down 4.8%.

EPS (Diluted)

$3.50

YoY-9.6%

QoQ-2.5%

5Y CAGR+6.0%

10Y CAGR+8.0%

Factset Research Systems earned $3.50 per diluted share (EPS) in Q3 2026. This represents a decrease of 9.6% from the same quarter a year earlier. Against the prior quarter it is down 2.5%.

Cash & Balance Sheet

Free Cash Flow

$254.0M

YoY+11.1%

QoQ+36.8%

5Y CAGR+15.9%

10Y CAGR+11.1%

Factset Research Systems generated $254.0M in free cash flow in Q3 2026, representing cash available after capex. This represents an increase of 11.1% from the same quarter a year earlier. Against the prior quarter it is up 36.8%.

Cash & Debt

$288.1M

YoY-19.2%

QoQ+7.4%

5Y CAGR-15.2%

10Y CAGR+4.4%

Factset Research Systems held $288.1M in cash against $890.5M in long-term debt as of Q3 2026.

Dividends Per Share

$1.16

YoY+5.5%

QoQ+5.5%

Factset Research Systems paid $1.16 per share in dividends in Q3 2026. This represents an increase of 5.5% from the same quarter a year earlier. Against the prior quarter it is up 5.5%.

Shares Outstanding

36M

YoY-5.9%

QoQ-2.4%

5Y CAGR-1.2%

10Y CAGR-1.3%

Factset Research Systems had 36M shares outstanding in Q3 2026. This represents a decrease of 5.9% from the same quarter a year earlier. Against the prior quarter it is down 2.4%.

Margins & Returns

Gross Margin

49.9%

YoY-2.2pp

QoQ-1.5pp

Factset Research Systems's gross margin was 49.9% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is down 2.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.5 percentage points.

Operating Margin

26.7%

YoY-6.5pp

QoQ-3.6pp

5Y change-2.8pp

10Y change-4.4pp

Factset Research Systems's operating margin was 26.7% in Q3 2026, reflecting core business profitability. This is down 6.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.6 percentage points.

Net Margin

20.3%

YoY-5.0pp

QoQ-1.4pp

5Y change-4.9pp

10Y change-2.9pp

Factset Research Systems's net profit margin was 20.3% in Q3 2026, showing the share of revenue converted to profit. This is down 5.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.4 percentage points.

Return on Equity

6.2%

YoY-0.7pp

QoQ0.0pp

5Y change-3.5pp

10Y change-6.0pp

Factset Research Systems's ROE was 6.2% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is down 0.7 percentage points from the same quarter a year earlier. It is unchanged from the prior quarter.

Capital Allocation

Share Buybacks

$203.1M

YoY+151.6%

QoQ+24.6%

5Y CAGR+28.7%

10Y CAGR+10.2%

Factset Research Systems spent $203.1M on share buybacks in Q3 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 151.6% from the same quarter a year earlier. Against the prior quarter it is up 24.6%.

Capital Expenditures

$30.5M

YoY+20.8%

QoQ+17.2%

5Y CAGR+10.3%

10Y CAGR+14.0%

Factset Research Systems invested $30.5M in capex in Q3 2026, funding long-term assets and infrastructure. This represents an increase of 20.8% from the same quarter a year earlier. Against the prior quarter it is up 17.2%.

R&D Spending

Not reported for Q3 2026.

FDS Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

FDS quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$2.4B	$2.3B+5.4%	$2.2B+5.6%	$2.1B+13.1%	$1.8B+15.9%	$1.6B+6.5%	$1.5B+4.1%	$1.4B+6.3%	$1.4B+10.6%	$1.2B+8.3%	$1.1B+12.0%	$1.0B+9.4%	$920.3M+7.3%	$858.1M+6.5%	$805.8M+10.9%	$726.5M
Cost of Revenue	$1.2B	$1.1B+8.5%	$1.0B+4.0%	$973.2M+11.7%	$871.1M+10.8%	$786.4M+13.1%	$695.4M+4.8%	$663.4M+0.6%	$659.3M+16.4%	$566.6M+16.2%	$487.4M	N/A	N/A	N/A	N/A	N/A
Gross Profit	$1.3B	$1.2B+2.8%	$1.2B+7.1%	$1.1B+14.3%	$972.8M+20.8%	$805.0M+0.8%	$798.7M+3.5%	$771.9M+11.7%	$690.8M+5.5%	$654.6M+2.3%	$639.7M	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	$300.7M+13.4%	$265.2M-0.8%	$267.4M+4.8%	$255.1M+2.0%	$250.1M+11.7%	$224.0M+4.3%	$214.7M-1.1%	$217.1M+1.0%	$215.0M	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$532.3M	$475.7M-2.9%	$489.8M+1.4%	$483.1M+11.6%	$433.0M+30.8%	$331.0M-3.4%	$342.5M+2.6%	$333.9M+2.8%	$324.6M+7.3%	$302.5M+4.3%	$290.0M+7.6%	$269.5M+1.9%	$264.4M-6.3%	$282.3M+9.7%	$257.3M+5.6%	$243.6M
Operating Income	$720.7M	$748.3M+6.7%	$701.3M+11.5%	$629.2M+32.3%	$475.5M+0.3%	$474.0M+7.8%	$439.7M+0.4%	$438.0M+19.6%	$366.2M+4.0%	$352.1M+0.7%	$349.7M+5.4%	$331.9M+9.8%	$302.2M+12.2%	$269.4M-1.3%	$273.0M+14.5%	$238.3M
EBITDA	N/A	$906.0M+9.6%	$826.5M+12.5%	$734.6M+30.7%	$562.2M+4.4%	$538.5M+8.3%	$497.3M-0.2%	$498.5M+17.7%	$423.5M+5.8%	$400.4M+3.3%	$387.7M+6.7%	$363.3M+7.9%	$336.7M+10.3%	$305.2M-0.5%	$306.8M+11.5%	$275.2M
Interest Expense	$54.6M	$57.7M-11.7%	$65.4M-1.3%	$66.3M+88.6%	$35.2M+335.8%	$8.1M-37.5%	$12.9M-34.8%	$19.8M+24.5%	$15.9M+89.3%	$8.4M+639.4%	$1.1M	N/A	N/A	N/A	N/A	N/A
Income Tax	$128.3M	$123.9M+8.3%	$114.4M-1.2%	$115.8M+148.0%	$46.7M-31.4%	$68.0M+25.5%	$54.2M-21.7%	$69.2M-18.4%	$84.8M-1.5%	$86.1M-29.6%	$122.2M+31.8%	$92.7M+0.9%	$91.9M+27.2%	$72.3M-15.9%	$85.9M+26.5%	$67.9M
Net Income	$566.0M	$597.0M+11.2%	$537.1M+14.7%	$468.2M+18.0%	$396.9M-0.7%	$399.6M+7.1%	$372.9M+5.7%	$352.8M+32.1%	$267.1M+3.4%	$258.3M-23.8%	$338.8M+40.6%	$241.1M+13.9%	$211.5M+6.5%	$198.6M+5.2%	$188.8M+10.4%	$171.0M
EPS (Basic)	N/A	$15.74+11.6%	$14.11+15.1%	$12.26+17.0%	$10.48-0.8%	$10.56+7.4%	$9.83+6.3%	$9.25+34.1%	$6.90+5.3%	$6.55-21.0%	$8.29+42.9%	$5.80+16.5%	$4.98+9.9%	$4.53+7.3%	$4.22+13.4%	$3.72
EPS (Diluted)	$15.17	$15.55+11.8%	$13.91+15.5%	$12.04+17.5%	$10.25-1.1%	$10.36+7.4%	$9.65+6.3%	$9.08+33.9%	$6.78+4.1%	$6.51-20.5%	$8.19+43.4%	$5.71+16.1%	$4.92+10.6%	$4.45+8.0%	$4.12+14.1%	$3.61
Diluted Shares (Avg)	N/A	38M-0.6%	39M-0.7%	39M+0.4%	39M+0.4%	39M-0.2%	39M-0.6%	39M-1.3%	39M-0.7%	40M-4.2%	41M-2.1%	42M-1.7%	43M-3.7%	45M-2.6%	46M-3.3%	47M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Revenue	$622.9M+6.4%	$611.0M+7.1%	$607.6M+6.9%	$596.9M+6.2%	$585.5M+5.9%	$570.7M+4.5%	$568.7M+4.9%	$562.2M+4.9%
Cost of Revenue	$312.2M+11.2%	$296.7M+10.1%	$287.9M+11.3%	$288.7M+11.8%	$280.7M+13.7%	$269.6M+5.7%	$258.8M+2.8%	$258.2M-2.1%
Gross Profit	$310.7M+1.9%	$314.3M+4.4%	$319.7M+3.2%	$308.2M+1.4%	$304.8M-0.3%	$301.1M+3.5%	$309.9M+6.6%	$304.0M+11.7%
SG&A Expenses	$144.4M+30.5%	$129.3M+11.9%	$127.6M+7.7%	$130.9M-25.7%	$110.6M+7.1%	$115.6M+6.2%	$118.6M+16.7%	$176.1M+12.1%
Operating Income	$166.3M-14.3%	$185.0M-0.3%	$192.1M+0.4%	$177.3M+38.7%	$194.2M-4.1%	$185.5M+2.0%	$191.3M+1.2%	$127.9M+10.1%
EBITDA	$212.2M-9.7%	$228.7M+2.1%	$236.2M+4.0%	$220.0M+35.9%	$235.0M0.0%	$223.9M+4.9%	$227.1M+5.1%	$161.9M+13.4%
Interest Expense	$13.8M-8.5%	$13.0M-6.2%	$13.4M-6.9%	$14.4M-7.3%	$15.1M-8.9%	$13.9M-16.3%	$14.4M-14.2%	$15.5M-6.8%
Income Tax	$27.4M-12.7%	$28.1M+2.2%	$37.5M+26.3%	$35.3M+27.9%	$31.4M-3.1%	$27.5M-0.9%	$29.7M+11.5%	$27.6M-34.5%
Net Income	$126.7M-14.7%	$133.1M-8.1%	$152.6M+1.7%	$153.6M+71.6%	$148.5M-6.1%	$144.9M+2.8%	$150.0M+1.0%	$89.5M+37.4%
EPS (Basic)	$3.51-10.5%	$3.60-5.5%	$4.08+3.3%	$4.06+72.8%	$3.92-5.5%	$3.81+3.0%	$3.95+1.0%	$2.35+36.6%
EPS (Diluted)	$3.50-9.6%	$3.59-4.5%	$4.06+4.4%	$4.02+72.5%	$3.87-5.4%	$3.76+3.0%	$3.89+1.3%	$2.33+37.9%
Diluted Shares (Avg)	36M-5.6%	37M-3.8%	38M-2.3%	N/A	38M-0.8%	39M-0.4%	39M-0.3%	N/A

Not reported in any period shown, so not listed: R&D Expenses.

FDS Balance Sheet

FDS quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$4.3B+6.1%	$4.1B+2.3%	$4.0B-1.3%	$4.0B+80.4%	$2.2B+6.8%	$2.1B+33.5%	$1.6B+9.9%	$1.4B+0.4%	$1.4B+38.7%	$1.0B+38.3%	$736.7M+11.1%	$663.2M-3.9%	$690.2M-0.6%	$694.1M+5.6%	$657.4M
Current Assets	$729.8M-12.7%	$835.8M+8.5%	$770.1M-11.5%	$870.3M-6.8%	$933.6M+10.9%	$841.9M+44.2%	$583.8M+35.5%	$430.9M+5.3%	$409.4M+10.9%	$369.3M+21.4%	$304.2M+21.8%	$249.8M-21.5%	$318.0M+6.3%	$299.1M+9.5%	$273.2M
Cash & Equivalents	$337.7M-20.2%	$423.0M-0.6%	$425.4M-15.5%	$503.3M-26.2%	$681.9M+16.4%	$585.6M+62.8%	$359.8M+72.5%	$208.6M+7.1%	$194.7M-14.7%	$228.4M+43.7%	$158.9M+36.5%	$116.4M-40.8%	$196.6M+4.0%	$189.0M+4.1%	$181.7M
Short-Term Investments	$17.4M-74.9%	$69.6M+116.1%	$32.2M-3.0%	$33.2M-7.7%	$36.0M+83.9%	$19.6M-24.2%	$25.8M-11.8%	$29.3M-9.8%	$32.4M+34.0%	$24.2M+3.1%	$23.5M+17.4%	$20.0M+57.2%	$12.7M-8.6%	$13.9M	$0
Accounts Receivable	$270.7M+18.7%	$228.1M-4.0%	$237.7M+16.4%	$204.1M+35.0%	$151.2M-2.5%	$155.0M+5.9%	$146.3M-6.6%	$156.6M+5.6%	$148.3M+51.7%	$97.8M+2.9%	$95.1M+5.2%	$90.4M+23.3%	$73.3M-1.3%	$74.3M-1.0%	$75.0M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$1.3B+27.1%	$1.0B+0.6%	$1.0B+4.0%	$965.8M+2115.2%	$43.6M-93.9%	$709.7M+3.5%	$685.7M-2.3%	$701.8M-0.8%	$707.6M+56.2%	$452.9M+46.9%	$308.3M+7.9%	$285.6M+16.8%	$244.6M-0.5%	$245.8M+7.7%	$228.3M
Total Liabilities	$2.1B-1.2%	$2.1B-8.6%	$2.3B-12.7%	$2.7B+122.0%	$1.2B+1.8%	$1.2B+33.7%	$887.9M-0.6%	$893.5M+4.7%	$853.6M+70.1%	$501.8M+144.7%	$205.1M+34.8%	$152.1M+2.5%	$148.4M+4.6%	$141.9M-0.3%	$142.3M
Current Liabilities	$521.3M-21.9%	$667.1M+37.8%	$484.3M+10.5%	$438.3M+38.8%	$315.7M+14.3%	$276.3M+26.2%	$218.9M-1.0%	$221.1M+9.9%	$201.1M+27.1%	$158.2M+13.2%	$139.8M+9.8%	$127.3M+7.6%	$118.3M+4.5%	$113.2M+3.4%	$109.4M
Non-Current Liabilities	$1.6B+8.2%	$1.5B-20.6%	$1.9B-17.2%	$2.2B+151.4%	$892.9M-2.0%	$910.7M+36.1%	$669.0M-0.5%	$672.4M+3.1%	$652.5M+89.9%	$343.6M+426.1%	$65.3M+162.9%	$24.8M-17.7%	$30.2M+5.1%	$28.7M-12.6%	$32.8M
Long-Term Debt	$1.4B+10.2%	$1.2B-23.0%	$1.6B-18.7%	$2.0B+245.0%	$574.5M0.0%	$574.4M0.0%	$574.2M-0.1%	$574.8M0.0%	$575.0M+91.7%	$300.0M+757.1%	$35.0M	$0	N/A	N/A	N/A
Total Equity	$2.2B+14.3%	$1.9B+18.1%	$1.6B+21.7%	$1.3B+31.0%	$1.0B+13.4%	$896.4M+33.3%	$672.3M+27.8%	$525.9M-6.0%	$559.7M+8.2%	$517.4M-2.7%	$531.6M+4.0%	$511.1M-5.7%	$541.8M-1.9%	$552.3M+7.2%	$515.2M
Retained Earnings	$2.3B+23.0%	$1.9B+25.5%	$1.5B+27.6%	$1.2B+29.3%	$912.5M+44.1%	$633.1M+69.6%	$373.2M+203.8%	$122.8M-91.6%	$1.5B+13.6%	$1.3B+25.7%	$1.0B+20.3%	$849.5M+21.3%	$700.5M+25.2%	$559.7M-38.6%	$912.1M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Total Assets	$4.2B-3.4%	$4.2B-0.5%	$4.2B+4.3%	$4.3B+6.1%	$4.3B+7.4%	$4.2B+6.3%	$4.0B+2.5%	$4.1B+2.3%
Current Assets	$727.5M-4.3%	$724.2M+2.3%	$708.6M-5.6%	$729.8M-12.7%	$760.5M-11.4%	$707.6M-14.0%	$750.7M-2.0%	$835.8M+8.5%
Cash & Equivalents	$288.1M-19.2%	$268.3M-3.7%	$275.4M-4.7%	$337.7M-20.2%	$356.4M-21.4%	$278.5M-27.0%	$289.2M-29.8%	$423.0M-0.6%
Short-Term Investments	$16.1M+109.8%	$16.9M+99.8%	$17.2M-75.2%	$17.4M-74.9%	$7.7M-88.8%	$8.5M-87.6%	$69.6M+117.1%	$69.6M+116.1%
Accounts Receivable	$290.0M+6.7%	$320.2M+15.3%	$289.0M+14.4%	$270.7M+18.7%	$271.9M+13.2%	$277.6M+2.0%	$252.5M+2.9%	$228.1M-4.0%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$1.3B+0.4%	$1.3B+3.4%	$1.3B+17.2%	$1.3B+27.1%	$1.3B+27.2%	$1.2B+24.0%	$1.1B+8.6%	$1.0B+0.6%
Total Liabilities	$2.2B-1.1%	$2.1B-4.3%	$2.1B-0.2%	$2.1B-1.2%	$2.2B+1.6%	$2.2B-0.2%	$2.1B-8.6%	$2.1B-8.6%
Current Liabilities	$1.1B+105.2%	$505.9M+5.0%	$458.8M-14.7%	$521.3M-21.9%	$518.9M-22.7%	$481.8M+4.8%	$538.1M+18.0%	$667.1M+37.8%
Non-Current Liabilities	$1.1B-34.2%	$1.6B-6.9%	$1.6B+5.0%	$1.6B+8.2%	$1.7B+12.6%	$1.7B-1.5%	$1.5B-15.4%	$1.5B-20.6%
Long-Term Debt	$890.5M-37.7%	$1.4B-7.0%	$1.4B+5.6%	$1.4B+10.2%	$1.4B+15.3%	$1.5B-1.2%	$1.3B-16.4%	$1.2B-23.0%
Total Equity	$2.0B-5.7%	$2.1B+3.5%	$2.2B+8.9%	$2.2B+14.3%	$2.2B+14.0%	$2.1B+14.2%	$2.0B+17.1%	$1.9B+18.1%
Retained Earnings	$2.6B+18.2%	$2.5B+20.1%	$2.4B+21.8%	$2.3B+23.0%	$2.2B+20.3%	$2.1B+22.3%	$2.0B+23.7%	$1.9B+25.5%

Not reported in any period shown, so not listed: Inventory.

FDS Cash Flow Statement

FDS quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$829.6M	$726.3M+3.7%	$700.3M+8.5%	$645.6M+19.9%	$538.3M-3.1%	$555.2M+9.8%	$505.8M+18.4%	$427.1M+10.8%	$385.7M+20.3%	$320.5M-3.2%	$331.1M+8.1%	$306.4M+15.6%	$265.0M-1.8%	$269.8M+16.3%	$232.0M+12.0%	$207.1M
Depreciation & Amortization	N/A	$157.7M+26.0%	$125.2M+18.8%	$105.4M+21.6%	$86.7M+34.4%	$64.5M+11.9%	$57.6M-4.7%	$60.5M+5.5%	$57.3M+18.6%	$48.3M+26.9%	$38.1M+21.4%	$31.3M-9.0%	$34.4M-3.8%	$35.8M+5.9%	$33.8M-8.3%	$36.8M
Stock-Based Compensation	N/A	$61.2M-3.6%	$63.5M+2.4%	$62.0M+10.8%	$56.0M+24.3%	$45.1M+23.2%	$36.6M+12.9%	$32.4M+2.8%	$31.5M-7.8%	$34.2M+14.7%	$29.8M+13.0%	$26.4M+15.2%	$22.9M-42.7%	$40.0M+81.7%	$22.0M-14.7%	$25.8M
Capital Expenditures	$121.3M	$108.8M+27.0%	$85.7M+41.0%	$60.8M+18.8%	$51.2M-16.6%	$61.3M-21.0%	$77.6M+30.8%	$59.4M+77.1%	$33.5M-9.1%	$36.9M-22.8%	$47.7M+85.9%	$25.7M+44.7%	$17.7M-4.2%	$18.5M-17.8%	$22.5M-23.3%	$29.3M
Free Cash Flow	$708.3M	$617.5M+0.5%	$614.7M+5.1%	$584.8M+20.0%	$487.1M-1.4%	$493.9M+15.3%	$428.2M+16.4%	$367.8M+4.4%	$352.1M+24.1%	$283.7M+0.1%	$283.4M+0.9%	$280.8M+13.5%	$247.3M-1.6%	$251.3M+20.0%	$209.4M+17.8%	$177.8M
Investing Cash Flow	-$92.8M	-$392.8M-172.2%	-$144.3M-51.3%	-$95.4M+95.3%	-$2.0B-1395.4%	-$136.0M-84.7%	-$73.6M-31.3%	-$56.1M-15.6%	-$48.5M+86.0%	-$347.3M-119.2%	-$158.4M-144.2%	-$64.9M+8.2%	-$70.7M-246.4%	-$20.4M+65.3%	-$58.8M-100.6%	-$29.3M
Financing Cash Flow	-$812.2M	-$407.8M+27.3%	-$560.9M+11.3%	-$632.0M-147.2%	$1.3B+515.0%	-$322.7M-48.0%	-$218.1M-1.8%	-$214.3M+33.0%	-$320.0M-3821.5%	-$8.2M+91.0%	-$91.0M+51.4%	-$187.3M+32.3%	-$276.7M-16.1%	-$238.4M-50.2%	-$158.7M+20.3%	-$199.1M
Dividends Paid	$164.3M	$160.0M+6.2%	$150.7M+8.7%	$138.6M+10.1%	$125.9M+6.8%	$117.9M+6.8%	$110.4M+10.4%	$100.1M+11.9%	$89.4M+10.5%	$80.9M+9.0%	$74.2M+11.5%	$66.6M+9.1%	$61.0M+8.9%	$56.0M+12.0%	$50.0M+13.7%	$43.9M
Share Buybacks	$612.6M	$300.5M+27.7%	$235.2M+33.1%	$176.7M+848.1%	$18.6M-93.0%	$264.7M+32.6%	$199.6M-9.4%	$220.4M-27.5%	$304.0M+16.5%	$261.0M-26.9%	$356.8M+39.3%	$256.2M-8.4%	$279.8M-15.8%	$332.2M+116.2%	$153.6M-29.1%	$216.6M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Operating Cash Flow	$284.5M+12.1%	$211.7M+21.7%	$121.3M+40.4%	$212.1M+30.0%	$253.8M+6.5%	$174.0M+21.0%	$86.4M-44.3%	$163.2M+4.8%
Depreciation & Amortization	$45.9M+12.3%	$43.7M+13.7%	$44.1M+23.6%	$42.7M+25.5%	$40.8M+25.7%	$38.4M+21.6%	$35.7M+32.0%	$34.0M+27.5%
Stock-Based Compensation	$22.2M+30.6%	$20.9M+26.1%	$18.5M+35.8%	N/A	$17.0M+8.1%	$16.5M-0.6%	$13.6M-5.0%	N/A
Capital Expenditures	$30.5M+20.8%	$26.0M+9.5%	$30.8M+19.2%	$34.0M+30.8%	$25.2M+18.2%	$23.7M+8.3%	$25.9M+57.1%	$26.0M+3988.0%
Free Cash Flow	$254.0M+11.1%	$185.7M+23.6%	$90.4M+49.5%	$178.1M+29.8%	$228.6M+5.4%	$150.2M+23.3%	$60.5M-56.4%	$137.2M-11.5%
Investing Cash Flow	-$47.5M-51.9%	-$26.2M+86.4%	$4.3M+103.0%	-$23.4M+41.0%	-$31.2M-46.4%	-$193.1M-232.3%	-$145.1M-475.2%	-$39.7M-71.8%
Financing Cash Flow	-$217.1M-41.2%	-$196.1M-899.6%	-$190.5M-171.9%	-$208.5M-32.0%	-$153.8M-7.0%	$24.5M+121.4%	-$70.1M+51.5%	-$157.9M+18.9%
Dividends Paid	$40.3M+2.0%	$41.0M+3.5%	$41.4M+5.5%	$41.6M+5.8%	$39.5M+6.3%	$39.6M+6.7%	$39.2M+5.9%	$39.4M+5.8%
Share Buybacks	$203.1M+151.6%	$163.0M+153.3%	$139.9M+186.7%	$106.6M+68.4%	$80.7M+35.0%	$64.4M+23.1%	$48.8M-18.6%	$63.3M-42.2%

FDS Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

FDS quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	52.7%-1.3pp	54.1%+0.7pp	53.3%+0.6pp	52.8%+2.2pp	50.6%-2.9pp	53.4%-0.3pp	53.8%+2.6pp	51.2%-2.4pp	53.6%-3.2pp	56.8%	N/A	N/A	N/A	N/A	N/A
Operating Margin	32.2%+0.4pp	31.8%+1.7pp	30.2%+4.4pp	25.8%-4.0pp	29.8%+0.4pp	29.4%-1.1pp	30.5%+3.4pp	27.1%-1.7pp	28.8%-2.2pp	31.0%-2.0pp	33.0%+0.1pp	32.8%+1.4pp	31.4%-2.5pp	33.9%+1.1pp	32.8%
Net Margin	25.7%+1.3pp	24.4%+1.9pp	22.4%+0.9pp	21.5%-3.6pp	25.1%+0.2pp	25.0%+0.4pp	24.6%+4.8pp	19.8%-1.4pp	21.1%-8.9pp	30.1%+6.1pp	23.9%+1.0pp	23.0%-0.2pp	23.2%-0.3pp	23.4%-0.1pp	23.5%
Return on Equity	27.3%-0.8pp	28.1%-0.8pp	28.9%-0.9pp	29.8%-9.5pp	39.3%-2.3pp	41.6%-10.9pp	52.5%+1.7pp	50.8%+4.7pp	46.1%-19.4pp	65.5%+20.1pp	45.4%+4.0pp	41.4%+4.7pp	36.7%+2.5pp	34.2%+1.0pp	33.2%
Return on Assets	13.9%+0.6pp	13.3%+1.4pp	11.8%+1.9pp	9.9%-8.1pp	18.0%+0.1pp	17.9%-4.7pp	22.6%+3.8pp	18.8%+0.6pp	18.3%-15.0pp	33.2%+0.5pp	32.7%+0.8pp	31.9%+3.1pp	28.8%+1.6pp	27.2%+1.2pp	26.0%
Current Ratio	1.40+0.1x	1.25-0.3x	1.59-0.4x	1.99-1.0x	2.96-0.1x	3.05+0.4x	2.67+0.7x	1.95-0.1x	2.04-0.3x	2.33+0.2x	2.18+0.2x	1.96-0.7x	2.690.0x	2.64+0.1x	2.50
Debt-to-Equity	0.630.0x	0.65-0.3x	1.00-0.5x	1.49+0.9x	0.57-0.1x	0.64-0.2x	0.85-0.2x	1.09+0.1x	1.03+0.4x	0.58+0.5x	0.07+0.1x	0.00-0.3x	0.270.0x	0.260.0x	0.28
Asset Turnover	0.540.0x	0.540.0x	0.53+0.1x	0.46-0.3x	0.720.0x	0.72-0.2x	0.920.0x	0.95+0.1x	0.86-0.2x	1.11-0.3x	1.370.0x	1.39+0.1x	1.24+0.1x	1.16+0.1x	1.11
FCF Margin	26.6%-1.3pp	27.9%-0.1pp	28.0%+1.6pp	26.4%-4.6pp	31.0%+2.4pp	28.7%+3.0pp	25.6%-0.5pp	26.1%+2.8pp	23.2%-1.9pp	25.1%-2.7pp	27.9%+1.0pp	26.9%-2.4pp	29.3%+3.3pp	26.0%+1.5pp	24.5%

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Gross Margin	49.9%-2.2pp	51.4%-1.3pp	52.6%-1.9pp	51.6%-2.4pp	52.0%-3.3pp	52.8%-0.5pp	54.5%+0.9pp	54.1%+3.3pp
Operating Margin	26.7%-6.5pp	30.3%-2.2pp	31.6%-2.0pp	29.7%+7.0pp	33.2%-3.5pp	32.5%-0.8pp	33.7%-1.2pp	22.7%+1.1pp
Net Margin	20.3%-5.0pp	21.8%-3.6pp	25.1%-1.3pp	25.7%+9.8pp	25.4%-3.2pp	25.4%-0.4pp	26.4%-1.0pp	15.9%+3.8pp
Return on Equity	6.2%-0.7pp	6.3%-0.8pp	7.0%-0.5pp	7.0%+2.4pp	6.9%-1.5pp	7.0%-0.8pp	7.5%-1.2pp	4.7%+0.7pp
Return on Assets	3.0%-0.4pp	3.1%-0.3pp	3.6%-0.1pp	3.6%+1.4pp	3.4%-0.5pp	3.4%-0.1pp	3.7%-0.1pp	2.2%+0.6pp
Current Ratio	0.68-0.8x	1.430.0x	1.54+0.1x	1.40+0.1x	1.47+0.2x	1.47-0.3x	1.40-0.3x	1.25-0.3x
Debt-to-Equity	0.44-0.2x	0.64-0.1x	0.630.0x	0.630.0x	0.660.0x	0.72-0.1x	0.65-0.3x	0.65-0.3x
Asset Turnover	0.150.0x	0.140.0x	0.140.0x	0.140.0x	0.140.0x	0.130.0x	0.140.0x	0.140.0x
FCF Margin	40.8%+1.7pp	30.4%+4.1pp	14.9%+4.2pp	29.8%+5.4pp	39.0%-0.2pp	26.3%+4.0pp	10.6%-14.9pp	24.4%-4.5pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Factset Research Systems FDS	FY2025	$2.3B	$597.0M	25.7%	$10.3B	68/100
TransUnion TRU	FY2025	$4.6B	$455.4M	10.0%	$12.9B	56/100
Morningstar, Inc. MORN	FY2025	$2.4B	$374.2M	15.3%	$7.7B	62/100
Cboe Global Markets, Inc. CBOE	FY2025	$4.7B	$1.1B	23.3%	$30.5B	—
MSCI, Inc. MSCI	FY2025	$3.1B	$1.2B	38.4%	$40.8B	66/100
Nasdaq, Inc. NDAQ	FY2025	$8.3B	$1.8B	21.6%	$52.3B	61/100

Where Factset Research Systems Ranks

Frequently Asked Questions

What is Factset Research Systems's annual revenue?

Factset Research Systems (FDS) reported $2.3B in total revenue for fiscal year 2025. This represents a 5.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Factset Research Systems's revenue growing?

Factset Research Systems (FDS) revenue grew by 5.4% year-over-year, from $2.2B to $2.3B in fiscal year 2025.

Is Factset Research Systems profitable?

Yes, Factset Research Systems (FDS) reported a net income of $597.0M in fiscal year 2025, with a net profit margin of 25.7%.

What is Factset Research Systems's EBITDA?

Factset Research Systems (FDS) had EBITDA of $906.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Factset Research Systems have?

As of fiscal year 2025, Factset Research Systems (FDS) had $337.7M in cash and equivalents against $1.4B in long-term debt.

What is Factset Research Systems's gross margin?

Factset Research Systems (FDS) had a gross margin of 52.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Factset Research Systems's operating margin?

Factset Research Systems (FDS) had an operating margin of 32.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Factset Research Systems's net profit margin?

Factset Research Systems (FDS) had a net profit margin of 25.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Factset Research Systems's return on equity (ROE)?

Factset Research Systems (FDS) has a return on equity of 27.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Factset Research Systems's free cash flow?

Factset Research Systems (FDS) generated $617.5M in free cash flow during fiscal year 2025. This represents a 0.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Factset Research Systems's operating cash flow?

Factset Research Systems (FDS) generated $726.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Factset Research Systems's total assets?

Factset Research Systems (FDS) had $4.3B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Factset Research Systems's capital expenditures?

Factset Research Systems (FDS) invested $108.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Factset Research Systems spend on research and development?

Factset Research Systems (FDS) invested $300.7M in research and development during fiscal year 2025.

Does Factset Research Systems buy back shares?

Yes, Factset Research Systems (FDS) spent $300.5M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Factset Research Systems have outstanding?

Factset Research Systems (FDS) had 37M shares outstanding as of fiscal year 2025.

What is Factset Research Systems's current ratio?

Factset Research Systems (FDS) had a current ratio of 1.40 as of fiscal year 2025, which is considered adequate.

What is Factset Research Systems's debt-to-equity ratio?

Factset Research Systems (FDS) had a debt-to-equity ratio of 0.63 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Factset Research Systems's return on assets (ROA)?

Factset Research Systems (FDS) had a return on assets of 13.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Factset Research Systems's P/E ratio?

Factset Research Systems (FDS) trades at 18.2x earnings, its market capitalization divided by net income of $566.0M net income, trailing 12 months to May 31, 2026. The market capitalization is $10.3B as of Oct 14, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Factset Research Systems's price-to-sales ratio?

Factset Research Systems (FDS) trades at 4.2x sales, its market capitalization divided by revenue of $2.4B revenue, trailing 12 months to May 31, 2026. The market capitalization is $10.3B as of Oct 14, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Factset Research Systems's Altman Z-Score?

Factset Research Systems (FDS) has an Altman Z-Score of 4.85, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Factset Research Systems's Piotroski F-Score?

Factset Research Systems (FDS) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Factset Research Systems's earnings high quality?

Factset Research Systems (FDS) has an earnings quality ratio of 1.22x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Factset Research Systems cover its interest payments?

Factset Research Systems (FDS) has an interest coverage ratio of 12.96x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Factset Research Systems?

Factset Research Systems (FDS) scores 68 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.